Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2025-12-30 @ 4:42 PM
Study NCT ID:
NCT04829435
Status:
COMPLETED
Last Update Posted:
2021-07-01
First Post:
2021-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)
Sponsor:
Allena Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-31
First Submit QC Date:
None
Study First Post Date:
2021-04-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-29
Last Update Post Date:
2021-07-01
Last Update Post Date Type:
ACTUAL